Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Fortis Escorts Heart Institute, Okhla provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1988, the NABL hospital is based in Delhi, India, with 310 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Kasemrad Ramkhamhaeng Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 1992, the JCI hospital is located in Bangkok, Thailand, with 120 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Dubai, United Arab Emirates
At Zulekha Hospital Dubai, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2004, the JCI hospital is located in Dubai, United Arab Emirates, and has 179 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
At Liv Hospital Ulus, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2013, the JCI hospital is located in Istanbul, Turkey, and has 154 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
At Indraprastha Apollo Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1996, the JCI hospital is located in Delhi, India, and has 710 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Prime Hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1999, the ACHS, JCI hospital is based in Dubai, United Arab Emirates, with 100 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Medicana International Samsun Hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2011, the JCI hospital is based in Samsun, Turkey, with 249 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
With advanced orthopaedic and cartilage-care infrastructure, Medicana International Istanbul offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1992, the JCI hospital is located in Istanbul, Turkey, and has 186 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Medicana International Ankara Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2008, the JCI hospital is located in Ankara, Turkey, with 215 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Memorial Antalya Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2010, the JCI hospital is located in Antalya, Turkey, with 114 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
VM Medical Park Ankara provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2014, the JCI hospital is based in Ankara, Turkey, with 327 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Medical Park Antalya Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2008, the JCI hospital is situated in Antalya, Turkey, with 228 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Apollo Hospitals provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1988, the JCI hospital is based in Hyderabad, India, with 550 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Star Hospitals offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2008, the NABH, NABL hospital is situated in Hyderabad, India, with 435 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Global Health City offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1999, the NABH, NABL hospital is situated in Chennai, India, with 200 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
